The single nucleotide polymorphism (SNP) in BTN3A3 was negatively correlated with the risk of ovarian cancer 62, and BTN3A3 was associated with a lower risk of ovarian cancer recurrence 15. This evidence concerns the gene BTN3A3 and ovarian carcinoma.